Double-Expressor Lymphoma

Explore clinical trials studying Double-Expressor Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Double-Expressor Lymphoma trial results

Recruiting

NCT07069699

Conditions: Burkitt Lymphoma, DNA Virus Infections, Double-Expressor Lymphoma, +16 more
Locations: UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

University of Kansas Clinical Research Center Fairway, Kansas, United States

University of Kansas Cancer Center Kansas City, Kansas, United States

Recruiting

NCT05600686

Conditions: Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, +1 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

UC San Diego Moores Cancer Center San Diego, California, United States

Recruiting

NCT06674096

Active, Not Recruiting

NCT03984448

Conditions: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Diffuse Large B-cell Lymphoma, Double-Expressor Lymphoma, +16 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

View all 635 locations